1. Chuh A, Chan H, Zawar V. Pityriasis rosea: evidence for and against an infectious aetiology. Epidemiol Infect. 2004; 132:381–90.
2. Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006; 54:82–5.
Article
3. Watanabe T, Kawamura T, Jacob SE, et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol. 2002; 119:793–7.
Article
4. Drago F, Ciccarese G, Broccolo F, Cozzani E, Parodi A. Pityriasis rosea in children: clinical features and laboratory investigations. Dermatology. 2015; 231:9–14.
Article
5. Broccolo F, Drago F, Careddu AM, et al. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol. 2005; 124:1234–40.
Article
6. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007; 7:179–90.
Article
7. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol. 2004; 25:381–6.
Article
8. Yang F, Han XP. Expression of Toll-like receptor 3, 7 and 9 in peripheral blood lymphocytes from patients with pityriasis rosea. Chin J Dermatol. 2012; 45:130–2.
9. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29:e45.
Article
10. Ataseven A, Kurtipek GS, Akyurek FT, Kucukosmanoglu I, Dilek N. Unilateral pityriasis rosea. Indian Dermatol Online J. 2014; 5:528–9.
Article
11. Carty M, Bowie AG. Recent insights into the role of Toll-like receptors in viral infection. Clin Exp Immunol. 2010; 161:397–406.
Article
12. Miller RL, Meng TC, Tomai MA. The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect. 2008; 21:69–87.
Article
13. Lau YF, Tang LH, Ooi EE. A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic. Vaccine. 2009; 27:1354–64.
Article
14. Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev. 2008; 21:13–25.
Article
15. Renn CN, Sanchez DJ, Ochoa MT, et al. TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J Immunol. 2006; 177:298–305.
Article